51 related articles for article (PubMed ID: 17343790)
21. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
22. In vivo monitoring the fate of Cy5.5-Tat labeled T lymphocytes by quantitative near-infrared fluorescence imaging during acute brain inflammation in a rat model of experimental autoimmune encephalomyelitis.
Berger C; Gremlich HU; Schmidt P; Cannet C; Kneuer R; Hiestand P; Rausch M; Rudin M
J Immunol Methods; 2007 May; 323(1):65-77. PubMed ID: 17433359
[TBL] [Abstract][Full Text] [Related]
23. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
24. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
25. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
26. [Construction of recombinant plasmid pVAX1-microdystrophin and preliminary study on the treatment to Duchenne muscular dystrophy].
Xiong F; Zhang C; Zheng H; Xiao S; Yu M; Xu Y; Liu Z; Zhou C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):624-8. PubMed ID: 19065517
[TBL] [Abstract][Full Text] [Related]
27. Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis.
Martín-Saavedra FM; Flores N; Dorado B; Eguiluz C; Bravo B; García-Merino A; Ballester S
Mol Immunol; 2007 Jul; 44(14):3597-607. PubMed ID: 17420051
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.
Liston A; Kohler RE; Townley S; Haylock-Jacobs S; Comerford I; Caon AC; Webster J; Harrison JM; Swann J; Clark-Lewis I; Korner H; McColl SR
J Immunol; 2009 Mar; 182(5):3121-30. PubMed ID: 19234209
[TBL] [Abstract][Full Text] [Related]
29. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
[TBL] [Abstract][Full Text] [Related]
30. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
31. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
32. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
33. The innate immune response to adjuvants dictates the adaptive immune response to autoantigens.
Staykova MA; Liñares D; Fordham SA; Paridaen JT; Willenborg DO
J Neuropathol Exp Neurol; 2008 Jun; 67(6):543-54. PubMed ID: 18520773
[TBL] [Abstract][Full Text] [Related]
34. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model.
Belmar NA; Lombardo JR; Chao DT; Li O; Ma X; Pong-Afar M; Law DA; Starling GC
J Neuroimmunol; 2009 Jul; 212(1-2):65-73. PubMed ID: 19477024
[TBL] [Abstract][Full Text] [Related]
36. Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins.
Hamana A; Takahashi Y; Tanioka A; Nishikawa M; Takakura Y
Int J Pharm; 2018 Jan; 536(1):310-317. PubMed ID: 29217470
[TBL] [Abstract][Full Text] [Related]
37. Preliminary study on immunotoxin for the prevention of Schistosomiasis japonica.
Feng Z; Li Y; Qiu Z; Li Y; Peng T; Guan X
Chin Med J (Engl); 2001 Jul; 114(7):772. PubMed ID: 11780349
[No Abstract] [Full Text] [Related]
38. New anti-T cell immunotoxins for the clinic.
Frankel AE
Leuk Res; 2005 Mar; 29(3):249-51. PubMed ID: 15661259
[No Abstract] [Full Text] [Related]
39. [Primary study of the recombinant immunotoxin DT390-mRantes in EAE therapy].
Jia Y; Li H; Chen WJ; Lu ML; Li MY; Jiang ZH; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):236-9. PubMed ID: 17343790
[TBL] [Abstract][Full Text] [Related]
40. In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis.
Chen W; Li H; Jia Y; Lv M; Li M; Feng P; Hu H; Zhang L
J Autoimmun; 2007 Feb; 28(1):30-40. PubMed ID: 17267177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
